These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The new generation of antipsychotic drugs. Tamminga CA; Lahti AC Int Clin Psychopharmacol; 1996 May; 11 Suppl 2():73-6. PubMed ID: 8803664 [TBL] [Abstract][Full Text] [Related]
15. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders]. Hilger E; Kasper S Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312 [TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. Bressan RA; Jones HM; Pilowsky LS J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196 [TBL] [Abstract][Full Text] [Related]
17. Side effect profiles of new antipsychotic agents. Casey DE J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170 [TBL] [Abstract][Full Text] [Related]
18. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Correll CU; Leucht S; Kane JM Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963 [TBL] [Abstract][Full Text] [Related]
19. Risperidone and tardive dyskinesia: a case of blepharospasm. Mullen A Aust N Z J Psychiatry; 2000 Oct; 34(5):879-80. PubMed ID: 11037386 [No Abstract] [Full Text] [Related]
20. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Nelson MW; Reynolds RR; Kelly DL; Conley RR Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]